D'Urzo Nunzia, Martinelli Manuele, Pezzicoli Alfredo, De Cesare Virginia, Pinto Vittoria, Margarit Immaculada, Telford John Laird, Maione Domenico
Novartis Vaccines and Diagnostics, Siena, Italy.
Appl Environ Microbiol. 2014 Apr;80(7):2176-85. doi: 10.1128/AEM.03627-13. Epub 2014 Jan 31.
Streptococcus agalactiae, also known as group B Streptococcus (GBS), is a primary colonizer of the anogenital mucosa of up to 40% of healthy women and an important cause of invasive neonatal infections worldwide. Among the 10 known capsular serotypes, GBS type III accounts for 30 to 76% of the cases of neonatal meningitis. In recent years, the ability of GBS to form biofilm attracted attention for its possible role in fitness and virulence. Here, a new in vitro biofilm formation protocol was developed to guarantee more stringent conditions, to better discriminate between strong-, low-, and non-biofilm-forming strains, and to facilitate interpretation of data. This protocol was used to screen the biofilm-forming abilities of 366 GBS clinical isolates from pregnant women and from neonatal infections of different serotypes in relation to medium composition and pH. The results identified a subset of isolates of serotypes III and V that formed strong biofilms under acidic conditions. Importantly, the best biofilm formers belonged to serotype III hypervirulent clone ST-17. Moreover, the abilities of proteinase K to strongly inhibit biofilm formation and to disaggregate mature biofilms suggested that proteins play an essential role in promoting GBS biofilm initiation and contribute to biofilm structural stability.
无乳链球菌,也称为B族链球菌(GBS),是高达40%健康女性肛门生殖黏膜的主要定植菌,也是全球侵袭性新生儿感染的重要病因。在已知的10种荚膜血清型中,III型GBS占新生儿脑膜炎病例的30%至76%。近年来,GBS形成生物膜的能力因其在适应性和毒力方面的潜在作用而受到关注。在此,开发了一种新的体外生物膜形成方案,以确保更严格的条件,更好地区分强、低和非生物膜形成菌株,并便于数据解读。该方案用于筛选来自孕妇和不同血清型新生儿感染的366株GBS临床分离株在不同培养基组成和pH条件下的生物膜形成能力。结果鉴定出III型和V型血清型分离株的一个子集,它们在酸性条件下形成强生物膜。重要的是,最佳生物膜形成者属于III型高毒力克隆ST-17。此外,蛋白酶K强烈抑制生物膜形成和解聚成熟生物膜的能力表明,蛋白质在促进GBS生物膜起始中起重要作用,并有助于生物膜结构稳定性。